HAS ŞİMŞEK, D. Et Al. 2014. The evaluation of Ga68-peptide PET/CT and F18-FDG PET/CT findings in imaging the primary tumors and metastases of gastroenteropancreatic neuroendocrine tumors. 27. European Association of Nuclear Medicine , (Göteborg, Sweden), 355-356.

HAS ŞİMŞEK, D., KUYUMCU, S., ŞANLI, Y., TÜRKMEN, C., AYKAN, N. F., ÜNAL, S. N., ... ADALET, I.(2014). The evaluation of Ga68-peptide PET/CT and F18-FDG PET/CT findings in imaging the primary tumors and metastases of gastroenteropancreatic neuroendocrine tumors . 27. European Association of Nuclear Medicine (pp.355-356). Göteborg, Sweden

HAS ŞİMŞEK, Duygu Et Al. "The evaluation of Ga68-peptide PET/CT and F18-FDG PET/CT findings in imaging the primary tumors and metastases of gastroenteropancreatic neuroendocrine tumors," 27. European Association of Nuclear Medicine, Göteborg, Sweden, 2014

HAS ŞİMŞEK, Duygu H. Et Al. "The evaluation of Ga68-peptide PET/CT and F18-FDG PET/CT findings in imaging the primary tumors and metastases of gastroenteropancreatic neuroendocrine tumors." 27. European Association of Nuclear Medicine , Göteborg, Sweden, pp.355-356, 2014

HAS ŞİMŞEK, D. Et Al. (2014) . "The evaluation of Ga68-peptide PET/CT and F18-FDG PET/CT findings in imaging the primary tumors and metastases of gastroenteropancreatic neuroendocrine tumors." 27. European Association of Nuclear Medicine , Göteborg, Sweden, pp.355-356.

@conferencepaper{conferencepaper, author={Duygu HAS ŞİMŞEK Et Al. }, title={The evaluation of Ga68-peptide PET/CT and F18-FDG PET/CT findings in imaging the primary tumors and metastases of gastroenteropancreatic neuroendocrine tumors}, congress name={27. European Association of Nuclear Medicine}, city={Göteborg}, country={Sweden}, year={2014}, pages={355-356} }